FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to aerosol composition, suitable for application for treatment of bronchospasms and associated with them disorders, which contains therapeutically efficient amount of troventol, microground together with propellant and one or more pharmaceutically acceptable carrier. Composition preferably contains 40-640 mcg of troventol and carrier can be selected from surface-active substance, co-solvent, antioxidant and/or filling agent.
EFFECT: invention also relates to dosing inhalator which contains aerosol composition for treatment of bronchospasms and associated with them disorders.
22 cl, 6 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
CRYSTALLINE LEVOSALBUTAMOL SULFATE, METHOD OF ITS OBTAINING AND PHARMACEUTICAL COMPOSITION, WHICH CONTAINS IT | 2005 |
|
RU2440972C2 |
PHARMACEUTICAL AEROSOL COMPOSITION | 2009 |
|
RU2565438C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING RPL554 IN HFA-134A FOR ADMINISTRATION BY INHALATION | 2019 |
|
RU2813959C2 |
CYLINDER FOR DELIVERY OF PHARMACEUTICAL COMPOSITION, DOSING INHALATOR | 1992 |
|
RU2179037C2 |
PEPTIDE AND PROTEIN AEROSOL PREPARATIONS | 1995 |
|
RU2175866C2 |
MEDICINAL AEROSOL COMPOSITIONS | 2002 |
|
RU2294737C2 |
METHOD FOR PREPARING METERED DOSE SPRAYED INHALER FOR TREATING RESPIRATORY DISEASE | 2012 |
|
RU2582218C2 |
AEROSOL COMBINATION OF SALMETEROL AND FLUTICASONE FOR TREATING RESPIRATORY DISEASES | 2013 |
|
RU2521975C1 |
PHARMACEUTICAL COMPOSITION FOR AEROSOLS WITH TWO OR MORE NUMBERS OF ACTIVE COMPONENTS | 1999 |
|
RU2218152C2 |
INHALATION FORMULATION IN FORM OF AEROSOL FOR TREATING BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2012 |
|
RU2504402C1 |
Authors
Dates
2012-08-10—Published
2006-09-25—Filed